Panacea Biotec Limited (PANACEABIO.BO)

INR 465.0

(2.69%)

Total Assets Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual total assets in 2023 was 12.4 Billion INR , down -2.4% from previous year.
Panacea Biotec Limited's latest quarterly total assets in 2023 FY was 12.4 Billion INR , down -2.4% from previous quarter.
Panacea Biotec Limited reported annual total assets of 12.71 Billion INR in 2022, down -27.73% from previous year.
Panacea Biotec Limited reported annual total assets of 17.58 Billion INR in 2021, up 49.37% from previous year.
Panacea Biotec Limited reported quarterly total assets of - INR for 2023 Q1, down -100.0% from previous quarter.
Panacea Biotec Limited reported quarterly total assets of 12.4 Billion INR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Total Assets of Panacea Biotec Limited (2023 - 2004)

Year	Total Assets	Total Assets Growth
2023	12.4 Billion INR	-2.4%
2022	12.71 Billion INR	-27.73%
2021	17.58 Billion INR	49.37%
2020	11.77 Billion INR	-15.3%
2019	13.9 Billion INR	1.07%
2018	13.75 Billion INR	-14.43%
2017	16.07 Billion INR	-10.7%
2016	18 Billion INR	-0.16%
2015	18.02 Billion INR	-6.6%
2014	19.3 Billion INR	-0.66%
2013	19.43 Billion INR	5.65%
2012	18.39 Billion INR	-5.66%
2011	19.49 Billion INR	11.94%
2010	17.41 Billion INR	3.32%
2009	16.85 Billion INR	-1.5%
2008	17.11 Billion INR	31.67%
2007	12.99 Billion INR	37.76%
2006	9.43 Billion INR	-6.62%
2005	10.1 Billion INR	114.51%
2004	4.71 Billion INR	0.0%

Year	Total Assets	Total Assets Growth
2023 FY	12.4 Billion INR	-2.4%
2023 Q1	- INR	-100.0%
2023 Q4	12.4 Billion INR	0.0%
2023 Q2	12.72 Billion INR	0.0%
2023 Q3	- INR	-100.0%
2022 Q1	- INR	-100.0%
2022 Q3	- INR	-100.0%
2022 Q2	13.5 Billion INR	0.0%
2022 Q4	12.71 Billion INR	0.0%
2022 FY	12.71 Billion INR	-27.73%
2021 Q3	- INR	-100.0%
2021 FY	17.58 Billion INR	49.37%
2021 Q4	17.58 Billion INR	0.0%
2021 Q2	12.47 Billion INR	0.0%
2021 Q1	- INR	-100.0%
2020 Q2	11.38 Billion INR	0.0%
2020 Q4	11.77 Billion INR	0.0%
2020 Q1	- INR	-100.0%
2020 FY	11.77 Billion INR	-15.3%
2020 Q3	- INR	-100.0%
2019 Q3	- INR	-100.0%
2019 FY	13.9 Billion INR	1.07%
2019 Q1	- INR	-100.0%
2019 Q2	14.33 Billion INR	0.0%
2019 Q4	13.9 Billion INR	0.0%
2018 Q4	13.75 Billion INR	0.0%
2018 FY	13.75 Billion INR	-14.43%
2017 FY	16.07 Billion INR	-10.7%
2016 FY	18 Billion INR	-0.16%
2015 FY	18.02 Billion INR	-6.6%
2014 FY	19.3 Billion INR	-0.66%
2013 FY	19.43 Billion INR	5.65%
2012 FY	18.39 Billion INR	-5.66%
2011 FY	19.49 Billion INR	11.94%
2010 FY	17.41 Billion INR	3.32%
2009 FY	16.85 Billion INR	-1.5%
2008 FY	17.11 Billion INR	31.67%
2007 FY	12.99 Billion INR	37.76%
2006 FY	9.43 Billion INR	-6.62%
2005 FY	10.1 Billion INR	114.51%
2004 FY	4.71 Billion INR	0.0%

Peer Total Assets Comparison of Panacea Biotec Limited

Name	Total Assets	Total Assets Difference
Alfavision Overseas (India) Limited	1.78 Billion INR	-594.82%
Biocon Limited	560.7 Billion INR	97.787%
Blue Jet Healthcare Limited	10.58 Billion INR	-17.173%
Concord Biotech Limited	17 Billion INR	27.049%
Dishman Carbogen Amcis Limited	95.81 Billion INR	87.051%
FERMENTA BIOTECH LIMITED	5.47 Billion INR	-126.471%
GENOMIC VALLEY BIOTECH LIMITED	43.33 Million INR	-28528.837%
Lyka Labs Limited	1.56 Billion INR	-691.632%
SAMSRITA LABS LIMITED	155.51 Million INR	-7877.983%
Servoteach Industries Limited	1591.00 INR	-779811339.346%
SMS Lifesciences India Limited	3.9 Billion INR	-217.7%
Supriya Lifescience Limited	9.21 Billion INR	-34.675%
Syngene International Limited	61.51 Billion INR	79.832%
TAKE Solutions Limited	881.05 Million INR	-1308.183%
Titan Biotech Limited	1.56 Billion INR	-692.362%
Transgene Biotek Limited	324.4 Million INR	-3724.502%
Vanta Bioscience Limited	853.96 Million INR	-1352.845%